AR043717A1 - Composicion, uso y metodo para el mejoramiento de la inmunidad en animales - Google Patents
Composicion, uso y metodo para el mejoramiento de la inmunidad en animalesInfo
- Publication number
- AR043717A1 AR043717A1 ARP040100520A ARP040100520A AR043717A1 AR 043717 A1 AR043717 A1 AR 043717A1 AR P040100520 A ARP040100520 A AR P040100520A AR P040100520 A ARP040100520 A AR P040100520A AR 043717 A1 AR043717 A1 AR 043717A1
- Authority
- AR
- Argentina
- Prior art keywords
- animals
- cysteamine
- salt
- composition
- improve immunity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Husbandry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Uso para la cisteamina, una sal de la misma o una composición que contiene cisteamina o una sal de la misma, para mejorar la inmunidad en animales. Método para mejorar la inmunidad en animales. Reivindicación 24: Una composición para mejorar la inmunidad en animales caracterizada porque comprende cisteamina, o una sal de la misma. Reivindicación 29: Una composición de acuerdo con cualquiera de las reivindicaciones 24 a 28, caracterizada porque comprende entre 1 y 95 % en peso de cisteamina, o una sal de la misma, y una composición de materiales huésped para la inclusión de compuestos, que comprende un estabilizador seleccionado de un grupo que incluye ciclodextrina y sus derivados. Reivindicación 45: Un aditivo para alimentos balanceados para animales, cuyo objetivo es mejorar la inmunidad en animales, caracterizado porque comprende cisteamina, una sal de la misma, o una composición que contiene cisteamina, como se define en cualquiera de las reivindicaciones 24 a 44. Reivindicación 46: Un alimento balanceado para animales para mejorar la inmunidad en animales, caracterizado porque comprende cisteamina, una sal de la misma, o una composición que contiene cisteamina, como se define en cualquiera de las reivindicaciones 24 a 44.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0303843A GB2398497A (en) | 2003-02-19 | 2003-02-19 | Composition for improving immunity of animals |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043717A1 true AR043717A1 (es) | 2005-08-10 |
Family
ID=9953321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100520A AR043717A1 (es) | 2003-02-19 | 2004-02-19 | Composicion, uso y metodo para el mejoramiento de la inmunidad en animales |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060140906A1 (es) |
EP (1) | EP1594487A1 (es) |
JP (1) | JP2006517942A (es) |
KR (1) | KR20050102130A (es) |
CN (1) | CN1750816A (es) |
AR (1) | AR043717A1 (es) |
GB (1) | GB2398497A (es) |
TW (1) | TW200505415A (es) |
WO (1) | WO2004073700A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200528090A (en) * | 2004-01-13 | 2005-09-01 | Omega Bio Pharma I P 2 Ltd | Methods for treating stress and affecting biological immune systems |
JP4976281B2 (ja) | 2004-05-03 | 2012-07-18 | オメガ バイオ‐ファーマ(アイ.ピー.3)リミテッド | 代謝を調節するための材料および方法 |
CN100434118C (zh) * | 2005-09-27 | 2008-11-19 | 上海华扩达生化科技有限公司 | 半胱胺及其衍生物在制备提高疫苗抗体效价药物中的应用 |
AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
WO2007089670A2 (en) | 2006-01-27 | 2007-08-09 | The Regents Of The University Of California | Enterically coated cysteamine, cystamine and derivatives thereof |
KR20100091219A (ko) | 2007-11-30 | 2010-08-18 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 시스테아민 산물을 이용한 비-알코올성 지방성간염(nash) 치료 방법 |
GB0905451D0 (en) * | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
WO2010138419A2 (en) * | 2009-05-23 | 2010-12-02 | Obio Pharmaceutical (H.K.) Ltd. | Materials and methods for treating viral infections |
GB201021186D0 (en) | 2010-12-14 | 2011-01-26 | Novabiotics Ltd | Composition |
AR096628A1 (es) | 2013-06-17 | 2016-01-20 | Raptor Pharmaceuticals Inc | Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella |
US10537528B2 (en) | 2015-11-16 | 2020-01-21 | The Regents Of The University Of California | Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds |
US10143665B2 (en) | 2015-11-17 | 2018-12-04 | Horizon Orphan Llc | Methods for storing cysteamine formulations and related methods of treatment |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1055560B (it) * | 1974-05-02 | 1982-01-11 | Istituto Chemioterapico | Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali |
US4657932A (en) * | 1982-05-06 | 1987-04-14 | Massachusetts General Hospital | Method of treating prolactin-related disorders |
US4711897A (en) * | 1985-04-24 | 1987-12-08 | Smithkline Beckman Corporation | Animal feed methods and compositions using cysteamine |
US5605885A (en) * | 1988-05-05 | 1997-02-25 | Entremed, Inc. | Method for stimulating the immune system |
DE4305788C2 (de) * | 1993-02-25 | 1997-06-12 | Beiersdorf Ag | Kosmetische und dermatologische Formulierungen zum Schutze der Haut gegen Oxidationsprozesse |
EP0656773B1 (de) * | 1992-08-26 | 1997-04-02 | Beiersdorf Aktiengesellschaft | Verwendung von radikalfängern als immunmodulierende agentien in kosmetischen und dermatologischen zubereitungen |
FR2716625B1 (fr) * | 1994-02-25 | 1996-04-26 | Gouchet Franck Arno | Préparation et utilisation de formes pharmaceutiques et cosmétiques contenant des composés d'inclusion avec les cyclodextrines de cystéamine, sels de cystéamine, ou dérivés de la cystéamine, sous forme de sel ou non. |
CA2233015A1 (en) * | 1995-09-25 | 1997-04-03 | Samir Chachoua | Therapeutic applications using horse serum |
SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
EP0951841A1 (en) * | 1997-12-23 | 1999-10-27 | Societe Des Produits Nestle S.A. | Process for the preparation of flavouring compositions and use of these compositions in bakery products |
AU2656799A (en) * | 1998-02-04 | 1999-08-23 | Winthrop-University Hospital | Metal-thiols as imminomodulating agents |
WO2000066110A1 (en) * | 1999-04-29 | 2000-11-09 | Merck Patent Gmbh | Glycine cleavage system inhibitors as potential antipsychotics |
EP1322290A1 (en) * | 2000-10-06 | 2003-07-02 | Jagotec Ag | Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
CN1144585C (zh) * | 2000-12-13 | 2004-04-07 | 华扩达动物科学[I.P.2]有限公司 | 含有半胱胺或其盐类的促进动物快速生长的组合物及用途 |
GB2377874B (en) * | 2001-07-23 | 2005-06-22 | Walcom Bio Chemicals Ind Ltd | Poultry feed and the use thereof |
-
2003
- 2003-02-19 GB GB0303843A patent/GB2398497A/en not_active Withdrawn
-
2004
- 2004-02-17 US US10/546,127 patent/US20060140906A1/en not_active Abandoned
- 2004-02-17 KR KR1020057015349A patent/KR20050102130A/ko not_active Application Discontinuation
- 2004-02-17 WO PCT/EP2004/001476 patent/WO2004073700A1/en not_active Application Discontinuation
- 2004-02-17 JP JP2006501865A patent/JP2006517942A/ja not_active Withdrawn
- 2004-02-17 CN CNA2004800046300A patent/CN1750816A/zh active Pending
- 2004-02-17 EP EP04711590A patent/EP1594487A1/en not_active Withdrawn
- 2004-02-18 TW TW093103960A patent/TW200505415A/zh unknown
- 2004-02-19 AR ARP040100520A patent/AR043717A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050102130A (ko) | 2005-10-25 |
GB2398497A (en) | 2004-08-25 |
CN1750816A (zh) | 2006-03-22 |
WO2004073700A1 (en) | 2004-09-02 |
EP1594487A1 (en) | 2005-11-16 |
TW200505415A (en) | 2005-02-16 |
US20060140906A1 (en) | 2006-06-29 |
GB0303843D0 (en) | 2003-03-26 |
JP2006517942A (ja) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043717A1 (es) | Composicion, uso y metodo para el mejoramiento de la inmunidad en animales | |
CR7742A (es) | Formulaciones para uso veterinario que contienen productos de origen no animal | |
CR9620A (es) | Composicion agricola | |
RS20050934A (en) | Antibodies specific for sclerostin and methods fo r increasing bone mineralization | |
BRPI0516105A (pt) | composições de fator de crescimento derivado de plaqueta e métodos de uso destas | |
CL2013001673A1 (es) | Composicion acuosa que comprende aproximadamente 18% p/v de concentracion, donde al menos el 95% de las proteinas son igg; metodo mejorado para preparar dicha composición. | |
CL2008003684A1 (es) | Composicion farmaceutica que comprende una sal de aluminio, que tiene una relacion molar de aluminio a cloruro de 0,3:1 a 3:1 aproximadamente, ademas comprende zirconio; metodo de preparacion de la composicion; uso como antitranspirante. | |
MEP10209A (en) | Stable emulsion composition | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
AR064254A1 (es) | Maiz extraido con solvente | |
MX2008013619A (es) | Aumento del titulo para vacunacion en animales. | |
BRPI0407243A (pt) | Método e composição que usam astaxantina | |
ATE504286T1 (de) | Antitranspirant- oder deodorantzusammensetzungen | |
DK1641352T3 (da) | Sammensætninger til forbedret oxidativ status hos katte | |
MX2017005877A (es) | Uso de 3,3'-dimetoxi-4, 4'-dihidroxiestilbenos como una sustancia saborizante. | |
BRPI0417167A (pt) | composições para animais de estimação compreendendo oligofrutose de cadeia curta | |
MX2021002244A (es) | Cuerpo para un lapiz para escribir, trazar, dibujar o colorear. | |
CR9890A (es) | Composicion fungicida | |
GT200400188A (es) | 5-arilpirimidinas como agentes anticancerigenos | |
NO20083116L (no) | Alumina-partikler samt fremgangsmater for fremstilling derav | |
BRPI0608149A2 (pt) | sal de um agonista de dopamina, composição compreendendo o mesmo, uso e processo para sua preparação e composto intermediário | |
AR097143A1 (es) | Composición alimenticia mineral para lamer para rumiantes y método para prepararla | |
CL2016003155A1 (es) | Composiciones de cuidado bucal | |
BR112012002453A2 (pt) | uso de 2-amino-2-metil-1-propanol(amp),e, método para aumentar o ph de uma suspensão aquosa. | |
ATE535251T1 (de) | Stabile wässrige g-csf-haltige zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |